Stephen Hill

Chief Operating Officer at LYELL IMMUNOPHARMA, INC.

Net worth: 310 103 $ as of 31/05/2026

55 year

Health Technology

Consumer Services

Profile

Stephen Hill is currently Chief Operating Officer at Lyell Immunopharma, Inc. since 2021.
Formerly, Mr. Hill was Vice President-Bulk Manufacturing at Amgen, Inc. and SVP & Head-Global Biologics Operations at AstraZeneca PLC from 2018 to 2019.
Education includes undergraduate and MBA degrees from the University of Washington.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
LYELL IMMUNOPHARMA, INC. 0.08%	11/05/2026	17,894 ( 0.08% )	310 103 $	31/05/2026

Stephen Hill active positions

Companies	Position	Start
LYELL IMMUNOPHARMA, INC.	Chief Operating Officer	01/11/2021

All active positions of Stephen Hill

Former positions of Stephen Hill

Companies	Position	End
ASTRAZENECA PLC	Corporate Officer/Principal	01/06/2019
AMGEN INC.	Corporate Officer/Principal	-

See the detail of Stephen Hill's experience

Training of Stephen Hill

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephen Hill's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lyell Immunopharma, Inc. Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases	Health Technology